Beta Drugs Limited (BETA) — Financial Results | 22 July 2026
No summary available
About Beta Drugs Limited (BETA)
Healthcare · Pharmaceuticals · Listed on NSE
📡 Get AI alerts when BETA files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track BETA — Free💡 Ask AI about this filing
📊 More BETA filings
- 🟡 Board Meeting — 18 August 2026Beta Drugs Limited announced the board approved the allotment of 35,383 bonus equity shares to CCD h...
- Announcement — 27 July 2026Beta Drugs Limited presented its FY26 investor deck highlighting robust growth across oncology, IVF,...
- Announcement — 23 July 2026Beta Drugs Limited issued revised Limited Review Reports with UDIN to correct an oversight in its st...
- 🟡 deviation variation — 20 July 2026Beta Drugs Limited confirmed no deviation in the use of funds from its November 2024 preferential is...
- 🟡 Board Meeting — 20 July 2026Beta Drugs Limited announced its Q1FY27 results on 20 July 2026, reporting consolidated revenue of ₹...
🔥 Also filed on 22 July 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when BETA files new disclosures
Track BETA filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track BETA — FreeFree account · 2 AI queries/day